Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11667706 Methods of purifying recombinant anti-abeta antibodies
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Current Assignee
Genentech
0
Date Filed
September 24, 2020
0
Date of Patent
June 6, 2023
0
Patent Applicant
Genentech
0
Patent Application Number
17031468
0
Patent Citations
US Patent 7863426 Antibody purification
0
US Patent 8067182 Method of weak partitioning chromatography
0
US Patent 8088618 Anti-IL 13 antibodies and uses thereof
0
US Patent 8137561 Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
0
US Patent 8318160 Treatment of cancer with novel anti-IL13 monoclonal antibodies
0
US Patent 8449885 Anti-VEGF antibodies
0
US Patent 8435406 Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
0
US Patent 9605065 Anti-IL13 antibodies and uses thereof
0
US Patent 8491904 Isolation and purification of anti-IL-13 antibodies using protein A affinity chromatography
0
US Patent 7323553 Non-affinity purification of proteins
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11667706
0
Patent Primary Examiner
Prema M Mertz
0
CPC Code
C07K 16/18
0
Find more entities like US Patent 11667706 Methods of purifying recombinant anti-abeta antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE